Funding Rounds
Novadip Biosciences

Novadip Biosciences Series B (2021, $22M)

Novadip Biosciences

Regenerative tissue therapeutics platform to accelerate healing of large bone defects and injuries

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $22.04M

Raised Date: 2021-01-01